Royalty Report: Medical, Device, Diagnostic – Collection: 26981


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 7


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Delivery
  • Technical Know How

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26981

License Grant
The Licensor grants to LABS an exclusive perpetual, worldwide license to (i) use the Masimo Technology to develop Licensed Applications alone or combined with Masimo Applications and to develop Licensed Devices, (ii) to make, have made, use, and sell Licensed Devices, (iii) to sublicense the Masimo Technology for the development of or for use in Licensed Applications and Licensed Devices, and (iv) to sublicense the use, manufacture and sale of Licensed Devices.  Masimo Technology incorporates circuitry and software which, among other things, acquires and detects signals generated by red and infrared LEDs, and which is designed to extract arterial oxygen saturation and pulse rate values from such signals.
License Property
Masimo Applications means use of Masimo Set for Vital Signs Monitoring.  SpO(Sub 2), Measurement means noninvasive measurement of arterial oxygen saturation (accounting for at least Hb and HbO(Sub 2), and possibly accounting for HbCO and/or HbMeth), plethysmographic waveforms, and/or pulse rate from neonate, pediatric and adult subjects (excludes fetal measurement and venous oxygen saturation).  SpO(Sub 2) Sensor means reusable and disposable standard adult, pediatric and neonatal Sensors for use with making SpO(Sub 2) Measurements.  Standard SpO(Sub 2) Sensors currently manufactured by Masimo have the following model number.

Licensed Trademarks means the Masimo Set product designation and word mark(s).

IPSCIO Record ID: 3240

License Grant
The cross-licensing agreement with the Licensee, who is Licensor's development partner, is granting an exclusive, perpetual and worldwide license, with sublicense rights, to use all Masimo SET® owned by the Licensor for the monitoring of non-vital signs measurements and to develop and sell devices incorporating Masimo SET® for monitoring non-vital signs measurements in the Licensee Market.

The Licensor also granted the Licensee a non-exclusive, perpetual and worldwide license, with sublicense rights, to use Masimo SET® for the measurement of vital signs in the Licensee  Market.

Pursuant to the Cross-Licensing Agreement, the Licensor has licensed from the Licensee the right to make and distribute products in the Licensor Market that utilize rainbow® technology for the measurement of only carbon monoxide, methemoglobin, fractional arterial oxygen saturation and hemoglobin, which includes hematocrit

License Property
The Licensor invented Masimo Signal Extraction Technology®, or Masimo SET®, which provides the capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Pulse oximetry is the noninvasive measurement of the oxygen saturation level of arterial blood, or the blood that delivers oxygen to the body's tissues, and pulse rate.

Rainbow® SET platform utilizing both Masimo SET® and licensed rainbow® technology, includes devices cleared by the U.S. Food and Drug Administration, to noninvasively and continuously monitor multiple measurements that previously required invasive or complicated procedures.

Field of Use
The Licensee Market is defined as any product market in which a product is intended to be used by a patient or pharmacist rather than a professional medical caregiver regardless of the particular location of the sale, including sales to doctors, hospitals, alternate care market professionals or otherwise, provided the product is intended to be recommended, or resold, for use by the patient or pharmacist.

IPSCIO Record ID: 406

License Grant
Licensor grants to Licensee an option to purchase a license to make, use and sell devices incorporating Licensor's Technology for use in blood glucose measurement applications devices and total hemoglobin measurement applications devices for marketing or other distribution directly to, and only for use in, hospitals.  Such license shall be exclusive for the earlier of three (3) years following the date that such devices are ready for sale in such market, or four (4) years from the date that Licensor makes the technology available to Licensee.  Thereafter, this license shall be nonexclusive.  Such license shall include the right to sell such devices on an OEM basis (excluding companies in glucose monitoring business) to no more than two OEM companies at any one time.
Field of Use
Licensee desires an option to purchase a license to technology  developed by LABS for use in blood glucose monitoring applications in the  hospital market.

IPSCIO Record ID: 105571

License Grant
An amendment to the existing settlement agreement will continue to pay a royalty for its current pulse oximetry products sold in the United States through October 6, 2018, after which no further royalties will be due under the agreement.
License Property
Patent relates to pulse oximetry, a noninvasive method for monitoring a person's oxygen saturation.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 250

License Grant
After January 31, 2006, Licensee will no longer ship its current 05 pulse oximetry platform, but it will continue to provide service and sensors for previously sold products.  Licensor has granted Licensee the right to sell its new line of pulse oximetry products in exchange for an ongoing royalty.
License Property
The parties are involved in litigation in the United States District Court for the Central District of California, Civil Action Nos. CV 00-6506 MRP (AJWx) and CV 03-0603 MRP (AJWx) alleging claims under federal patent laws (the Patent Litigation).  The Parties are involved in litigation in the United States District Court for the Central District of California, Civil Action No. CV 02-4770 MRP (AJWx) alleging claims under federal antitrust laws (the Antitrust Litigation).  The parties desire to settle fully and finally all claims and disputes between the parties other than the Antitrust Litigation.

Licensor Patents means U.S. Patent Nos. 6,263,222, 6,157,850, and 5,769,785.

06 Pulse Oximetry Products means Licensee’s pulse oximetry products (including oximetry software licensed to OEMs) that use the 06 algorithm.

Field of Use
A pulse oximeter (saturometer) is a medical device that indirectly monitors the oxygen saturation of a patient's blood (as opposed to measuring oxygen saturation directly through a blood sample) and changes in blood volume in the skin, producing a photoplethysmograph.

IPSCIO Record ID: 1713

License Grant
The Licensors, two individuals, assigned all of their rights, title and interest throughout the world in, to and under certain improvements relating to blood analyzers and disposable syringes for use in medical analyzers in U.S. Patent No. 5,066,859, U.S. Patent Application Serial No. 07/789,088 and a Patent and Cooperation Treaty Patent Application entitled 'Hematocrit and Oxygen Saturation Blood Analyzer'.
License Property
U.S. Patent No. 5,066,859, 'Hematocrit and Oxygen Saturation Blood Analyzer'

IPSCIO Record ID: 211915

License Grant
Licensor hereby grants to Licensee an exclusive, worldwide, right and license to practice the Patent Rights and Know-How in the Field of Use to make, have made, develop, improve, use, promote, market and sell Sensors and Instruments, including the right to have third parties manufacture, sell and distribute on behalf of Licensee.
License Property
The licensed property are such patents and applications relating to a method and device for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face, including mouth and nasal regions, to assess or help assess systemic hypoperfusion.

Sensor as used in this Agreement means any device which detects signals either in or around
(1) the alimentary canal between the stomach and the mouth;
(2) the mouth;
(3) the nasal passages; or
(4) the respiratory region between the lungs and face (nose/mouth), to assess or help assess systemic hypoperfusion and that is covered by a validly issued U.S. patent included in the Patent Rights. Sensors can be disposable or reusable, and shall not include any part of an Instrument, which may connect to the Sensor to process electrical or optical signals from the Sensor.

Field of Use
Field of Use means applications for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face (including mouth and nasal regions) to assess or help assess systemic hypoperfusion, and specifically excludes all Field Forward Military Applications and all other applications not directly related to taking measurements in the alimentary and respiratory regions referred to herein to assess or help assess systemic hypoperfusion (e.g., measurements for regional tissue perfusion of any internal organ, appendage, etc.).
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.